53 related articles for article (PubMed ID: 33129512)
1. [Pharmacokinetic changes related to acute infection. Examples from the SARS-CoV-2 pandemic].
Chavant A; Gautier-Veyret E; Chhun S; Guilhaumou R; Stanke-Labesque F
Therapie; 2021; 76(4):319-333. PubMed ID: 33129512
[TBL] [Abstract][Full Text] [Related]
2. A lipidomic view of SARS-CoV-2.
Ebrahimi KH; McCullagh JSO
Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34313294
[TBL] [Abstract][Full Text] [Related]
3. Ischemic stroke in COVID-19-positive patients: an overview of SARS-CoV-2 and thrombotic mechanisms for the neurointerventionalist.
Zakeri A; Jadhav AP; Sullenger BA; Nimjee SM
J Neurointerv Surg; 2021 Mar; 13(3):202-206. PubMed ID: 33298508
[TBL] [Abstract][Full Text] [Related]
4. How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1.
Conti P; Gallenga CE; Tetè G; Caraffa A; Ronconi G; Younes A; Toniato E; Ross R; Kritas SK
J Biol Regul Homeost Agents; 2020 March-April,; 34(2):333-338. PubMed ID: 32228825
[TBL] [Abstract][Full Text] [Related]
5. Inflammation is a major regulator of drug metabolizing enzymes and transporters: Consequences for the personalization of drug treatment.
Stanke-Labesque F; Gautier-Veyret E; Chhun S; Guilhaumou R;
Pharmacol Ther; 2020 Nov; 215():107627. PubMed ID: 32659304
[TBL] [Abstract][Full Text] [Related]
6. Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.
Wakabayashi M; Pawankar R; Narazaki H; Ueda T; Itabashi T
Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):1-7. PubMed ID: 33186186
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug-Drug Interactions.
Elens L; Langman LJ; Hesselink DA; Bergan S; Moes DJAR; Molinaro M; Venkataramanan R; Lemaitre F
Ther Drug Monit; 2020 Jun; 42(3):360-368. PubMed ID: 32304488
[TBL] [Abstract][Full Text] [Related]
8. Juggling the COVID-19 pandemic: A cytopathology point of view.
Iaccarino A; Pisapia P; Vigliar E; Vielh P; Troncone G
Cytopathology; 2021 May; 32(3):299-303. PubMed ID: 33145830
[TBL] [Abstract][Full Text] [Related]
9. Anti-SARS-CoV-2 Potential of Artemisinins In Vitro.
Cao R; Hu H; Li Y; Wang X; Xu M; Liu J; Zhang H; Yan Y; Zhao L; Li W; Zhang T; Xiao D; Guo X; Li Y; Yang J; Hu Z; Wang M; Zhong W
ACS Infect Dis; 2020 Sep; 6(9):2524-2531. PubMed ID: 32786284
[TBL] [Abstract][Full Text] [Related]
10. Health literacy and changes in pattern of drug use among participants at the Stockholm Needle Exchange Program during the COVID-19 pandemic.
Lindqvist K; Wallmofeldt C; Holmén E; Hammarberg A; Kåberg M
Harm Reduct J; 2021 May; 18(1):52. PubMed ID: 33971892
[TBL] [Abstract][Full Text] [Related]
11. Clinical trials and the COVID-19 pandemic.
Retsas S
Hell J Nucl Med; 2020; 23(1):4-5. PubMed ID: 32361715
[TBL] [Abstract][Full Text] [Related]
12. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
[TBL] [Abstract][Full Text] [Related]
13. Molecular Binding Mechanism and Pharmacology Comparative Analysis of Noscapine for Repurposing against SARS-CoV-2 Protease.
Kumar N; Sood D; van der Spek PJ; Sharma HS; Chandra R
J Proteome Res; 2020 Nov; 19(11):4678-4689. PubMed ID: 32786685
[TBL] [Abstract][Full Text] [Related]
14. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
[TBL] [Abstract][Full Text] [Related]
15. Vascular Endothelial Growth Factor (VEGF) as a Vital Target for Brain Inflammation during the COVID-19 Outbreak.
Yin XX; Zheng XR; Peng W; Wu ML; Mao XY
ACS Chem Neurosci; 2020 Jun; 11(12):1704-1705. PubMed ID: 32485101
[TBL] [Abstract][Full Text] [Related]
16. Inappropriate risk perception for SARS-CoV-2 infection among Italian HCWs in the eve of COVID-19 pandemic.
Riccò M; Vezzosi L; Balzarini F; Bragazzi NL
Acta Biomed; 2020 May; 91(3):e2020040. PubMed ID: 32921735
[TBL] [Abstract][Full Text] [Related]
17. Elucidating of oxidative distress in COVID-19 and methods of its prevention.
Barciszewska AM
Chem Biol Interact; 2021 Aug; 344():109501. PubMed ID: 33974898
[TBL] [Abstract][Full Text] [Related]
18. Analytical and Clinical Analysis of Two Automated Anti-SARS-CoV-2 Immunoassays in Pre-Pandemic and Pandemic Patient Populations.
Yang J; Pederson EC; Hamilton C; Neibauer T; Robyak K; McGhee P; Speicher T; Zhu Y
J Appl Lab Med; 2021 Mar; 6(2):441-450. PubMed ID: 33152084
[TBL] [Abstract][Full Text] [Related]
19. Surveillance Metrics of SARS-CoV-2 Transmission in Central Asia: Longitudinal Trend Analysis.
Post LA; Benishay ET; Moss CB; Murphy RL; Achenbach CJ; Ison MG; Resnick D; Singh LN; White J; Chaudhury AS; Boctor MJ; Welch SB; Oehmke JF
J Med Internet Res; 2021 Feb; 23(2):e25799. PubMed ID: 33475513
[TBL] [Abstract][Full Text] [Related]
20. Coronavirus Disease 2019 (SARS-CoV-2) and polycystic ovarian disease: Is there a higher risk for these women?
Morgante G; Troìa L; De Leo V
J Steroid Biochem Mol Biol; 2021 Jan; 205():105770. PubMed ID: 33065278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
